Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents

J Med Chem. 2003 Jul 3;46(14):2813-5. doi: 10.1021/jm030213+.

Abstract

A series of boronic-chalcone derivatives were synthesized and tested for antitumor activity against human breast cancer cell lines. The results show the boronic-chalcones are more toxic to breast cancer cells compared to normal breast cells than other known chalcones.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Boron Compounds / chemical synthesis*
  • Boron Compounds / pharmacology
  • Cell Division / drug effects
  • Chalcone / analogs & derivatives*
  • Chalcone / chemical synthesis*
  • Chalcone / pharmacology
  • Drug Screening Assays, Antitumor
  • Humans
  • Nuclear Proteins*
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Boron Compounds
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Chalcone
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2